NeuroStar® TMS Advances Treatment for Adolescents During Mental Health Awareness Month
01 mai 2024 08h31 HE
|
Neuronetics
MALVERN, Pa., May 01, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of...
New Publication in Brain Stimulation Confirms Full TMS Treatment Course Is Vital
10 avr. 2024 08h31 HE
|
Neuronetics
MALVERN, Pa., April 10, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of...
NeuroStar® Advanced Therapy Receives FDA Clearance as a First-Line Add-On Treatment for Adolescents with Depression
25 mars 2024 08h30 HE
|
Neuronetics
MALVERN, Pa., March 25, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of...
Neuronetics Announces 5-Year Exclusive Partnership with Transformations Care Network
07 mars 2024 08h22 HE
|
Neuronetics
MALVERN, Pa., March 07, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of...
Neuronetics Launches Latest Evolution in its TrakStar® Patient Data Management System
12 févr. 2024 08h32 HE
|
Neuronetics
MALVERN, Pa., Feb. 12, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of...
NeuroStar TMS Patient Access Expands Through Lucet Health Policy Update
06 févr. 2024 08h28 HE
|
Neuronetics
MALVERN, Pa., Feb. 06, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of...
Neuronetics Receives 510(k) Clearance for NeuroSite™ Coil Placement Accessory
18 déc. 2023 08h49 HE
|
Neuronetics
MALVERN, Pa., Dec. 18, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of...
NeuroStar TMS Receives Expanded Regulatory Approval in Japan
04 déc. 2023 08h56 HE
|
Neuronetics
MALVERN, Pa., Dec. 04, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of...
NeuroStar Elevates Depression Treatment with Cutting-Edge Technology Advancements
13 nov. 2023 08h57 HE
|
Neuronetics
MALVERN, Pa., Nov. 13, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of...
Neuronetics Announces Continued Momentum from Health Plans for TMS Therapy Coverage
09 nov. 2023 08h32 HE
|
Neuronetics
MALVERN, Pa., Nov. 09, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve...